Tonsil-derived Mesenchymal Stem Cells Ameliorate CCl4-induced Liver Fibrosis in Mice Via Autophagy Activation
Authors
Affiliations
Liver transplantation is the treatment of choice for chronic liver failure, although it is complicated by donor shortage, surgery-related complications, and immunological rejection. Cell transplantation is an alternative, minimally invasive treatment option with potentially fewer complications. We used human palatine tonsil as a novel source of mesenchymal stem cells (T-MSCs) and examined their ability to differentiate into hepatocyte-like cells in vivo and in vitro. Carbon tetrachloride (CCl4) mouse model was used to investigate the ability of T-MSCs to home to the site of liver injury. T-MSCs were only detected in the damaged liver, suggesting that they are disease-responsive. Differentiation of T-MSCs into hepatocyte-like cells was confirmed in vitro as determined by expression of hepatocyte markers. Next, we showed resolution of liver fibrosis by T-MSCs via reduction of TGF-β expression and collagen deposition in the liver. We hypothesized that autophagy activation was a possible mechanism for T-MSC-mediated liver recovery. In this report, we demonstrate for the first time that T-MSCs can differentiate into hepatocyte-like cells and ameliorate liver fibrosis via autophagy activation and down-regulation of TGF-β. These findings suggest that T-MSCs could be used as a novel source for stem cell therapy targeting liver diseases.
Abd-Allah S, Khamis T, Samy W, Alsemeh A, Abdullah D, Hussein S Iran J Med Sci. 2024; 49(11):724-740.
PMID: 39678523 PMC: 11645418. DOI: 10.30476/ijms.2023.99524.3159.
Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges.
Shan Y, Zhang M, Tao E, Wang J, Wei N, Lu Y Signal Transduct Target Ther. 2024; 9(1):242.
PMID: 39271680 PMC: 11399464. DOI: 10.1038/s41392-024-01936-8.
Advances and clinical challenges of mesenchymal stem cell therapy.
Mei R, Wan Z, Yang C, Shen X, Wang R, Zhang H Front Immunol. 2024; 15:1421854.
PMID: 39100671 PMC: 11294097. DOI: 10.3389/fimmu.2024.1421854.
Kim Y, An S, Lee S, Lee J, Kim S, Ahn J Int J Mol Sci. 2023; 24(22).
PMID: 38003216 PMC: 10671788. DOI: 10.3390/ijms242216024.
Peng X, Yang H, Tao L, Xiao J, Zeng Y, Shen Y PeerJ. 2023; 11:e16060.
PMID: 37790613 PMC: 10542821. DOI: 10.7717/peerj.16060.